In fact, Kiecken says its possible that Health Canadas actions could force Biolyse Pharma Corp. to lay off its sixty employees. 키켄은 이번 폐쇄로 인해 파클리탁셀 가격이 인상될 수도 있다고 말합니다. But Health Canada says this last threat has no foundation in reality.